Meyka Pro banner
Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. (CRL) Stock Overview

Explore Charles River Laboratories International, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CRL●NYSE
HealthcareMedical - Diagnostics & Research
$335.52
$5.29(1.55%)
U.S. Market opens in NaNh NaNm

Charles River Laboratories International, Inc. (CRL)

Meyka AI Score

Z

Key Financials

Market Cap16.2B
P/E Ratio328.79
EPS (TTM)$9.90
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$363.05
3 Months$276.78
1 Year Target$199.08

CRL Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Charles River Laboratories International, Inc. (NYSE: CRL) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Charles River Laboratories International, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CRL on the NYSE shows an RSI of 51.01, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $199.08 for the NYSE listing.

Key metrics behind Charles River Laboratories International, Inc.'s NYSE-traded stock include a P/E ratio of 328.79 and a market capitalization of 16.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CRL on the NYSE.

Price Performance (NYSE: CRL)

1-Day Change
-0.69%
5-Day Change
-3.38%
1-Month Change
11.82%
3-Month Change
19.85%
6-Month Change
122.49%
Year-to-Date (YTD) Change
68.25%
1-Year Change
106.24%
3-Year Change
77.06%
5-Year Change
-14.97%
All-Time (Max) Change
1425.59%

Contact Information

781 222 6000
251 Ballardvale Street, Wilmington, MA, 01887

Company Facts

190,000 Employees
IPO DateJun 23, 2000
CountryUS
Actively Trading

Frequently Asked Questions